The involvement of sodium and calcium ions in the release of amino acid neurotransmitters from mouse cortical slices elicited by hyperforin

Life Sciences

Volumn 71, Issue 22, 2002, Pages 2645-2655

  Marsh, Wendy L ^a   Davies, John A ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Amino acid neurotransmitters; Brain slices; Calcium; Hyperforin

Indexed keywords

4 AMINOBUTYRIC ACID; ASPARTIC ACID; CALCIUM ION; GLUTAMIC ACID; GLYCINE; HYPERFORIN; POTASSIUM; SERINE; SODIUM ION; TETRODOTOXIN; VERATRIDINE;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN PERFUSION; BRAIN SLICE; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG EFFECT; EXTRACELLULAR CALCIUM; FEMALE; MALE; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; SODIUM TRANSPORT;

ANIMALS; ANTIDEPRESSIVE AGENTS; ASPARTIC ACID; BICYCLO COMPOUNDS; CALCIUM; CEREBRAL CORTEX; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; MALE; MICE; MICE, INBRED BALB C; NEUROTRANSMITTER AGENTS; PHLOROGLUCINOL; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; SODIUM; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; TERPENES; TETRODOTOXIN; VERATRIDINE;

HYPERICUM; HYPERICUM PERFORATUM;

EID: 0037131518     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02104-5     Document Type: Article

References (36)

1. Muller W.E., Rolli M., Schafer C., Hafner U. Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity. Pharmacopsychiatry. 30:1997;102-107.
2. Muller W.E., Singer A., Wonnemann M., Hafner U., Rolli M., Schafer C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiatry. 31(Suppl. 1):1998;16-21.
3. Chatterjee S.S., Noldner M., Koch E., Erdelmeier C. Antidepressant activity of hypericum perforatum and hyperforin: the neglected possibility. Pharmacopsychiatry. 31(Suppl. 1):1998;7-15.
4. Bhattacharya S.K., Chakrabarti A., Chatterjee S.S. Activity profiles of two hyperforin-containing hypericum extracts in behavioural models. Pharmacopsychiatry. 31:1998;22-29.
5. Kaehler S.T., Sinner C., Chatterjee S.S., Philippu A. Hyperforin enhances the extracellular concentrations of catecholamines, serotonin and glutamate in the rat locus coeruleus. Neuroscience Letters. 262:1999;199-202.
6. Laakmann G., Schule C., Baghai M., Kieser M. St John's Wort in mild to moderate Depression: The relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry. 31(Suppl. 1):1998;54-59.
7. Biber A., Fischer H., Romer A., Chatterjee S.S. Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers. Pharmacopsychiatry. 31:1998;36-43.
8. Chatterjee S.S., Bhattacharya S.K., Wonnemann M., Singer A., Muller W.E. Hyperforin as a possible antidepressant component of hypericum extracts. Life Sciences. 63:1998;499-510.
9. Wonnemann M., Singer A., Muller W.E. Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St. John's Wort: the role of amiloride sensitive sodium conductive pathways. Neuropsychopharmacology. (2):2000;188-197.
10. Chatterjee S.S., Filippov V., Lishko P., Maximyuk O., Noldner M., Krishtal O. Hyperforin attenuates various ionic conductance mechanisms in the isolated hippocampal neurones of rat. Life Sciences. 65:1999;2395-2405.
11. Chatterjee S.S., Biber A., Weibezahn C. Stimulation of glutamate, aspartate and gamma-aminobutyric acid release from synaptosomes by hyperforin. Pharmacopsychiatry. 34(Suppl. 1):2001;S11-S19.
12. Gobbi M., Valle F.D., Ciapparelli C., Diomede L., Morazzoni P., Verotta L., Caccia S., Cervo L., Mennini T. Hypericum perforatum L. extract does not inhibit 5-HT transporter in rat brain cortex. Naunyn-Schmiedeberg's Arch. Pharmacology. 360:1999;262-269.
13. Singer A., Wonnemann M., Muller W.E. Hyperforin, a major antidepressant constituent of St. John's Wort, inhibits serotonin uptake by elevating free intracellular Na+1. Journal Pharmacology and Experimental Therapeutics. 290:1999;1363-1368.
14. + current in cerebellar Purkinje neurons. Pflugers Archive. 440(3):2000;427-434.
15. Srinivasan J., Richens A., Davies J.A. The effect of the desglycinyl metabolite of remacemide hydrochloride (FPL 12495AA) and dizocilpine (MK-801) on endogenous amino acid release from mouse cortex. British Journal Pharmacology. 116(8):1995;3087-3092.
16. Barnes S., Leighton G.E., Davies J.A. A novel superfusion chamber for the measurement of endogenous glutamate release from cerebellar slices. Journal Neuroscience Methods. 23(1):1988;57-61.
17. Turnell D.C., Cooper J.D. Rapid assay for amino acids in serum or urine by pre-column derivatization and reversed-phase liquid chromatography. Clinical Chemistry. 28(3):1982;527-531.
18. Linde K., Ramirez G., Mulrow C.D., Pauls A., Weidenhammer W., Melchart D. St. John's wort for depression - an overview and meta-analysis of randomised clinical trials. British Medical Journal. 313(7052):1996;253-258.
19. Volz H.P. Controlled clinical trials of hypericum extracts in depressed patients - an overview. Pharmacopsychiatry. 30:1997;72-76.
20. Wheatley D. LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients - a controlled 6-week clinical trial. Pharmacopsychiatry. (30):1997;77-80.
21. Phillipp M., Kohnen R., Hiller K. Hypericum-Extract versus Imipramine or placebo in patients with moderate depression. Randomised multicenter study of treatment for eight weeks. British Medical Journal. 319:1999;1534-1539.
22. Woelk H. Comparison of St John's wort and imipramine for treating depression: randomised controlled trial. British Medical Journal. 321(7260):2000;536-539.
23. Schrader E. Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression. International Clinical Psychopharmacology. 15:2000;61-68.
24. Brenner R., Azbel V., Madhusoodanan S., Pawlowska M. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study. Clinical Therapeutics. 22:2000;411-419.
25. Ernst E., Rand J.I., Barnes J., Stevinson C. Adverse effect profile of the herbal antidepressant St. John's wort. European Journal Clinical Pharmacology. 54:1998;589-594.
26. Dimpfel W., Schober F., Mannel M. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG). Pharmacopsychiatry. 31:1998;30-35.
27. Schellenberg R., Sauer S., Dimpfel W. Pharmacodynamic effects of two different hypericum extracts in healthy volunteers measured by quantitative EEG. Pharmacopsychiatry. 31:1998;44-53.
28. Muller W.E., Singer A., Wonnemann M. Hyperforin-antidepressant activity by a novel mechanism of action. Pharmacopsychiatry. 34(Suppl. 1):2001;S98-S102.
29. Lester H.A., Mager S., Quick M.W., Corey J.L. Permeation properties of neurotransmitter transporters. Annual Review Pharmacology & Toxicology. 34:1994;219-249.
30. Dickie B.G., Davies J.A. Calcium channel blocking agents and potassium-stimulated release of glutamate from cerebellar slices. European Journal Pharmacology. 229:1992;97-99.
31. Koch E., Chatterjee S.S. Hyperforin stimulates intracellular calcium mobilisation and enhances extracellular acidification in DDT1-MF2 smooth muscle cells. Pharmacopsychiatry. 34(Suppl. 1):2001;S70-S73.
32. Krishtal O., Lozovaya N., Fisunov A., Tsintsadze T., Pankratov Y., Kopanitsa M., Chatterjee S.S. Modulation of ion channels in rat neurons by the constituents of Hypericum perforatum. Pharmacopsychiatry. 34(Suppl. 1):2001;S74-S82.
33. Scotti A.L., Chatton J.Y., Reuter H. Roles of Na(+)-Ca2+ exchange and of mitochondria in the regulation of presynaptic Ca2+ and spontaneous glutamate release. Philosophical Transactions Royal Society London B. 354:1999;357-364.
34. 3H] GABA from synaptosomes probably related to mitochondrial calcium mobilization. Journal Neurochemistry. 35:1980;915-921.
35. Romano-Silva M.A., Gomez M.V., Brammer M.J. Modulation of Ca(2+)-stimulated glutamate release from synaptosomes by Na+ entry through tetrodotoxin-sensitive channels. Biochemistry Journal. 304(Pt 2):1994;353-357.
36. Marsh W.L., Chatterjee S.S., Davies J.A. The effect of hyperforin on amino acid neurotransmitter release from mouse cortical slices. Amino Acids. 21(1):2001;88.